Moderna stock gains 1.34% as melanoma case faces execution test


Moderna stock: Phase 3 melanoma data strengthen oncology ...

Moderna Inc stock: Phase 3 melanoma data sharpen oncology ...

Piper Sandler raises target for Moderna stock to USD 230.00 ...

Melanoma vaccine data drive Moderna stock volatility before ...

Goldman Sachs lifts target for Moderna stock to USD 137.00 ...

Moderna reports 42 percent risk cut as Citi rates Moderna ...

Moderna Inc. stock: Brookline cuts FY2030 EPS estimate pre-market ...

Moderna stock trades at EUR 176.24 in weekend trading

Moderna stock trades at EUR 178.96 in weekend trading